The Patent Finder
US

Methods for Treating Cancer Using ANTI-PD-1 Antibodies in Combination with ANTI-CTLA-4 Antibodies

US 9,358,289 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended May 2, 2026 · High confidence

Filed Mar 27, 2014 as application 14/227,733 · Granted Jun 7, 2016
Base term plus 141 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
Term ended May 2, 2026
2006 2026
Clock starts
May 2, 2006
Term ended
May 2, 2026
Granted
Jun 7, 2016
base term after the term ends fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
141
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 9,084,776.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 141 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts May 2, 2006, when application PCT/JP2006/309606, the earliest non-provisional in its chain, was filed (this one was filed Mar 27, 2014)May 2, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+141 days, USPTO patent term adjustment recordSep 20, 2026High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 9,084,776)capped to May 2, 2026High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderMay 2, 2026High confidence

This family

US 8,008,449In force
Dec 2028
Dec 2028
US 8,779,105In force
Jun 2027
Jun 2027
US 9,358,289this patent
May 2026
May 2026
US 9,387,247Term ended
Oct 2026
Oct 2026
US 9,492,539Term ended
Oct 2026
Oct 2026
US 9,492,540Term ended
May 2026
May 2026
US 9,084,776Term ended
May 2026
May 2026
US 10,441,655In force
May 2027
May 2027
8 of 11 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jun 10, 2014
Reel 33069, frame 61
Korman, Alan J.; Srinivasan, Mohan; Wang, Changyu; Selby, Mark J.; Chen, Bing; Cardarelli, Josephine M.Medarex, Inc.Assignment of Assignor's Interest
Jun 10, 2014
Reel 33069, frame 339
Huang, HaichunMedarex, Inc.Assignment of Assignor's Interest
Jun 10, 2014
Reel 33124, frame 53
Medarex, Inc.Ono Pharmaceutical Co., Ltd.Assignment of Undivided 50% of Assignor's Interest
Jun 11, 2014
Reel 33080, frame 678
Medarex, Inc.Medarex, L.l.c.Merger
Nov 7, 2014
Reel 34126, frame 342
Medarex, L.l.c.E. R. Squibb & Sons, L.L.C.Merger
Feb 4, 2015
Reel 34905, frame 592
Korman, Alan J.; Srinivasan, Mohan; Wang, Changyu; Selby, Mark J.; Chen, Bingliang; Cardarelli, Josephine M.Medarex, Inc.Corrective Assignment to Correct the Incorrect Spelling of Inventor "Bing Chen" to "Bingliang Chen" Previously Recorded on Reel 033069 Frame 0061. Assignor(S) Hereby Confirms the Correct Spelling of Inventor as "Bingliang Chen".

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited